{"transactions":[{"id":1046535,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Option to purchase Common Stock","published_at":"2025-09-08T21:45:43.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal quarterly installments beginning on January 1, 2026."}],"balance_after":100000,"derivative":{"exercise_price":1.33,"expiration_date":"2035-08-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001641172-25-026890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109657/000164117225026890/ownership.xml","form_type":"4"}},{"id":1046534,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Option to purchase Common Stock","published_at":"2025-09-08T21:45:43.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal quarterly installments beginning on January 1, 2025."}],"balance_after":100000,"derivative":{"exercise_price":1.33,"expiration_date":"2035-08-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001641172-25-026890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000164117225026890/ownership.xml","form_type":"4"}},{"id":1046533,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Option to purchase Common Stock","published_at":"2025-09-08T21:45:43.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are fully vested and exercisable."}],"balance_after":100000,"derivative":{"exercise_price":1.33,"expiration_date":"2035-08-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001641172-25-026890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000164117225026890/ownership.xml","form_type":"4"}},{"id":1807981,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman/Interim CEO"}}],"security":"Common Stock","published_at":"2023-08-15T23:29:58.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0.287,"value":57400.0,"ownership":{"direct":true},"balance_after":856218,"source":{"system":"sec-edgar","filing":"0001493152-23-029061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223029061/ownership.xml","form_type":"4"}},{"id":1903128,"issuer":{"id":7132,"kind":"organization","name":"Prairie Operating Co.","symbol":"PROP"},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy","published_at":"2023-05-06T01:43:20.000Z","date":"2020-08-03","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":67500,"derivative":{"exercise_price":0.25,"exercise_date":"2021-08-03","expiration_date":"2025-08-02","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001493152-23-015707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162896/000149315223015707/ownership.xml","form_type":"4"}},{"id":1903127,"issuer":{"id":7132,"kind":"organization","name":"Prairie Operating Co.","symbol":"PROP"},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy","published_at":"2023-05-06T01:43:20.000Z","date":"2019-09-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.25,"exercise_date":"2019-09-12","expiration_date":"2024-09-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-23-015707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162896/000149315223015707/ownership.xml","form_type":"4"}},{"id":1903126,"issuer":{"id":7132,"kind":"organization","name":"Prairie Operating Co.","symbol":"PROP"},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-06T01:43:20.000Z","date":"2018-10-16","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":0.25,"exercise_date":"2018-10-16","expiration_date":"2023-10-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-23-015707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162896/000149315223015707/ownership.xml","form_type":"4"}},{"id":1903125,"issuer":{"id":7132,"kind":"organization","name":"Prairie Operating Co.","symbol":"PROP"},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-06T01:43:20.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":218571,"price":0.175,"value":38249.925,"ownership":{"direct":true},"balance_after":1144683,"source":{"system":"sec-edgar","filing":"0001493152-23-015707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162896/000149315223015707/ownership.xml","form_type":"4"}},{"id":1903124,"issuer":{"id":7132,"kind":"organization","name":"Prairie Operating Co.","symbol":"PROP"},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-06T01:43:20.000Z","date":"2023-05-03","kind":"purchase","planned":false,"acquired":true,"shares":916112,"price":0.109,"value":99856.208,"ownership":{"direct":true},"balance_after":926112,"source":{"system":"sec-edgar","filing":"0001493152-23-015707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162896/000149315223015707/ownership.xml","form_type":"4"}},{"id":1922046,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman/Interim CEO"}}],"security":"Common Stock","published_at":"2023-04-11T22:59:39.000Z","date":"2023-04-11","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.5,"value":25000.0,"ownership":{"direct":true},"balance_after":656218,"source":{"system":"sec-edgar","filing":"0001493152-23-011888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223011888/ownership.xml","form_type":"4"}},{"id":2039415,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman and Interim CEO"}}],"security":"Option to purchase Common Stock","published_at":"2023-02-01T11:05:38.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct, and the reporting person is involuntarily terminated by the registrant."}],"balance_after":500000,"derivative":{"exercise_price":0.837,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-23-003230","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315223003230/ownership.xml","form_type":"4"}},{"id":2205925,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chair. and Interim CEO"}}],"security":"Option to purchase Common Stock","published_at":"2022-07-20T01:48:20.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":2.48,"exercise_date":"2022-07-15","expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-019876","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315222019876/ownership.xml","form_type":"4"}},{"id":2205924,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chair. and Interim CEO"}}],"security":"Common Stock","published_at":"2022-07-20T01:48:20.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":278058,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":606218,"source":{"system":"sec-edgar","filing":"0001493152-22-019876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000149315222019876/ownership.xml","form_type":"4"}},{"id":2516718,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"10% Senior  Convertible  Debenture","published_at":"2021-11-12T17:01:45.000Z","date":"2021-02-25","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.4,"exercise_date":"2020-06-23","expiration_date":"2021-06-23","underlying":"Common Stock","underlying_shares":9859},"source":{"system":"sec-edgar","filing":"0001654954-21-012057","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421012057/section16.xml","form_type":"4"}},{"id":2516717,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"10% Senior  Convertible  Debenture","published_at":"2021-11-12T17:01:45.000Z","date":"2021-02-25","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"While the maturity date of the Debenture was September 7, 2019, the Registrant did not repay the\nDebenture on the maturity date and the Debenture remained outstanding until converted."}],"balance_after":0,"derivative":{"exercise_price":3.4,"exercise_date":"2018-09-07","underlying":"Common Stock","underlying_shares":40243},"source":{"system":"sec-edgar","filing":"0001654954-21-012057","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421012057/section16.xml","form_type":"4"}},{"id":2516716,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase  Common Stock","published_at":"2021-11-12T17:01:45.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares vest on February 16, 2021, 2022 and 2023."}],"balance_after":50000,"derivative":{"exercise_price":6.33,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001654954-21-012057","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421012057/section16.xml","form_type":"4"}},{"id":2516715,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-12T17:01:45.000Z","date":"2021-02-25","kind":"exercise","acquired":true,"shares":9859,"price":3.4,"value":33520.6,"ownership":{"direct":true},"balance_after":328160,"source":{"system":"sec-edgar","filing":"0001654954-21-012057","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421012057/section16.xml","form_type":"4"}},{"id":2516714,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-12T17:01:45.000Z","date":"2021-02-25","kind":"exercise","acquired":true,"shares":40243,"price":3.4,"value":136826.2,"ownership":{"direct":true},"balance_after":318301,"source":{"system":"sec-edgar","filing":"0001654954-21-012057","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421012057/section16.xml","form_type":"4"}},{"id":2516713,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":75722,"kind":"person","name":"Breen Michael Martin","position":1,"cik":"0001863633","reported_name":"Breen Michael Martin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-12T17:01:45.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":278058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of shares of restricted stock (\"RSAs\"). 1/3rd of the RSAs vest on January 13, 2021, 2022 and 2023."}],"balance_after":278058,"source":{"system":"sec-edgar","filing":"0001654954-21-012057","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495421012057/section16.xml","form_type":"4"}}]}